Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns a preliminary rating to SLAM 2026-1 Limited and SLAM 2026-1 LLC (together, SLAM 2026-1), an aviation ABS transaction. SLAM 2026-1 represents the fifth aviation ABS transaction sponsored by SKY Aero Management Limited and SKY Leasing, LLC (SKY or the Company). The Company is comprised of 47 individuals operating out of five offices with headquarters in Greenwich, Connecticut. As of March 31, 2026, the Company had 105 aircraft under management valued at ove...

EL DORADO, Ark.--(BUSINESS WIRE)--Murphy USA Inc. (NYSE: MUSA), a leading marketer of retail motor fuel products and convenience merchandise, today announced financial results for the three months ended March 31, 2026. Key Highlights: Net income was $136.3 million, or $7.28 per diluted share, in Q1 2026 compared to net income of $53.2 million, or $2.63 per diluted share, in Q1 2025. Total fuel contribution for Q1 2026 was 35.0 cpg, compared to 25.4 cpg in Q1 2025. Total retail gallons increased...

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Albany Engineered Composites (AEC), a segment of Albany International Corp. (NYSE: AIN), has received a long-term contract from Pratt & Whitney, an RTX business, to produce composite structural engine components for the commercial aviation Pratt & Whitney GTF™ engine. “We are honored to be selected by Pratt & Whitney for this critical composite engine content. This award reflects AEC’s ability to deliver high-volume, high-precision composite struct...

EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives through tissue and organ donation, transplantation, and research, today announced the appointment of Ladora (Dorrie) A. Dils, RN, BSN, MHA, CPTC, to its Board of Directors and existing Board member, David R. McAllister, MD, as Vice Chair. “Dorrie understands the complex clinical and very personal dynamics of organ and tissue donation,” said Joe Yaccarino, MTF Biologics’ President and Chief E...

DENVER--(BUSINESS WIRE)--VF Corporation Announces Fourth Quarter Fiscal 2026 Earnings and Conference Call Date...

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to sup...

SAN JOSE, Costa Rica--(BUSINESS WIRE)--Logistic Properties of the Americas (NYSE American: LPA) (“LPA” or the “Company”), a leading developer, owner and manager of institutional quality, Class A industrial and logistics real estate in Central and South America, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Wednesday, May 13, 2026 Time: After Market Close Conference Call Thursday, May 14, 2026 Time: 9:00 a.m. ET | 8:00 a.m. CT To participate,...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 7, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-202...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Enpro (NYSE: NPO) today declared a quarterly dividend of $0.32/share; payable on June 17, 2026, to shareholders of record as of close on June 3, 2026....

LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to extend the deadline to commence the previously announced tender offer to acquire all outstanding shares of Assertio to May 4, 2026. As previously announced on April 8, 2026, Assertio has entered into a definitive agreement (the “Garda Agreement”) to be acquired by Garda for $18.00 per share in...